Gentiva® Health Services Reports Second Quarter 2014 Results Updates Fiscal Year 2014 Guidance to Reflect Strong Year-to-Date Operating Results

ATLANTA, Aug. 5, 2014 /PRNewswire/ -- Gentiva Health Services, Inc. (NASDAQ: GTIV), one of the largest providers of home health, hospice and community care services in the United States, today reported second quarter 2014 results that surpassed Gentiva's previous guidance for the quarter.  The Company also adjusted fiscal year 2014 guidance to reflect the Company's strong year-to-date performance and now expects full-year 2014 adjusted EBITDA of $183 million to $195 million and adjusted income attributable to Gentiva shareholders of $0.95 to $1.15 on a diluted per share basis.  

Quarterly highlights include:

  • Adjusted income attributable to Gentiva shareholders per diluted share of $0.38.
  • Adjusted EBITDA of $54.3 million.
  • Free cash flow of $47.5 million.
  • Net revenues of $498.0 million.

Second quarter 2014 financial highlights include: 

  • Net income attributable to Gentiva shareholders of $10.0 million, or $0.27 per diluted share, compared to net income of $6.3 million, or $0.20 per diluted share, for the second quarter of 2013.
  • Adjusted income attributable to Gentiva shareholders of $13.9 million, compared with income of $6.8 million in the comparable 2013 period. On a diluted per share basis, adjusted income attributable to Gentiva shareholders was $0.38 for the second quarter of 2014 as compared to adjusted income attributable to Gentiva shareholders of $0.22 for the second quarter of 2013.
  • Adjusted earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) was $54.3 million in the second quarter of 2014 as compared to $39.0 million in the second quarter of 2013.  Adjusted EBITDA as a percentage of net revenues was 10.9% in the second quarter of 2014 versus 9.4% in the prior year period.  
  • Total net revenues of $498.0 million, an increase of 20% compared to $414.4 million for the quarter ended June 30, 2013.  Net revenues included home health episodic revenues of $236.2 million, an increase of 14% compared to $206.7 million in the 2013 second quarter.  Hospice revenues were $172.3 million, a decrease of 4% compared to $179.2 million in the 2013 second quarter.  Community Care revenues were $56.7 million for the second quarter of 2014.

Adjusted income attributable to Gentiva shareholders and Adjusted EBITDA exclude charges related to cost savings initiatives and acquisition and integration activities, losses on closed locations, merger related expenses and other special items.

"Gentiva's results this quarter were marked by significant revenue and margin growth across our business and speak to the continued success of our One Gentiva initiative and the strategic investments the Company has made over the past year," said Gentiva CEO Tony Strange.  "Reflecting our confidence in our strategy to increase shareholder value, we have raised the lower end of our fiscal year 2014 guidance based on these results and the momentum we are seeing as we continue to execute our business strategies."

Highlights for the six months ended June 30, 2014 include:  

  • Net income attributable to Gentiva shareholders of $10.3 million, or $0.28 per diluted share, compared to a net loss of $200.8 million, or $6.51 per diluted share, in the prior year period.
  • Adjusted income attributable to Gentiva shareholders of $18.7 million, compared with $13.9 million in the 2013 period. On a diluted per share basis, adjusted income attributable to Gentiva shareholders was $0.51 for 2014 as compared with $0.45 in the corresponding period of 2013. 
  • Adjusted earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) was $93.3 million as compared to $78.1 million in the 2013 period.  Adjusted EBITDA as a percentage of net revenues was 9.5% versus 9.4% in the prior year period.
  • Total net revenues of $985.5 million, an increase of 19% compared to $830.0 million for the prior year period. Net revenues included home health episodic revenues of $460.6 million, an increase of 11% as compared to $414.1 million in the comparable 2013 period.  Hospice revenues were $346.7 million, a decrease of 3% compared to $358.7 million in the comparable 2013 period.  Community Care revenues were $113.8 million for the first six months of 2014.

Cash Flow and Balance Sheet Highlights

At June 30, 2014, the Company reported cash and cash equivalents of $106.2 million, up from $62.9 million   at March 31, 2014.  Total outstanding debt was $1.17 billion as of June 30, 2014 and March 31, 2014. Total Company days sales outstanding, or DSOs, was 48 days at June 30, 2014, down from 50 days at March 31, 2014.

For the second quarter of 2014, net cash provided by operating activities was $50.4 million, compared to  $30.7 million in the prior year period.  Free cash flow increased 83% to $47.5 million for the second quarter of 2014, compared to $25.9 million in the prior year period.  Free cash flow is calculated as net cash provided by operating activities less capital expenditures.

Full-Year 2014 Outlook Comments

Based on the Company's strong year-to-date operating results, Gentiva now expects full year 2014 Adjusted EBITDA to be in the range of $183 million to $195 million and adjusted income attributable to Gentiva shareholders to be in the range of $0.95 to $1.15 on a diluted per share basis.  Gentiva now expects full-year 2014 net revenues to be in the range of $1.96 billion to $2.0 billion.

Gentiva's 2014 outlook includes the full-year impact of its Harden acquisition and the final 2014 Medicare  home health and hospice reimbursement rates issued by the Centers for Medicare and Medicaid Services (CMS).  The 2014 outlook excludes any ongoing losses from closed locations as the operations are wound down.

Non-GAAP Financial Measures

The information provided in this press release includes certain non-GAAP financial measures as defined under Securities and Exchange Commission (SEC) rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those historical measures to the most directly comparable GAAP measures.

A reconciliation of Adjusted EBITDA and adjusted income attributable to Gentiva shareholders to net income, the most directly comparable GAAP measure, is not accessible on a forward-looking basis without unreasonable effort due to the inherent difficulties in predicting the charges for cost savings initiatives and acquisition and integration activities, the results of discontinued operations and the impact of any future acquisitions or divestitures, which can fluctuate significantly and may have a significant impact on net income.

Conference Call and Webcast Details

The Company will comment further on its second quarter 2014 results during its conference call and live webcast to be held today, Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call #72785046. The webcast is an audio-only, one-way event. Webcast listeners who wish to ask questions must participate in the conference call. Log onto http://investors.gentiva.com/events.cfm to hear the webcast. A replay of the call will be available on August 5 and will remain available continuously through August 12. To listen to a replay of the call from the United States, Canada or international locations dial (800) 585-8367 or (404) 537-3406 and enter the following PIN at the prompt: 72785046. Visit http://investors.gentiva.com/events.cfm to access the webcast archive. This press release is accessible at http://investors.gentiva.com/releases.cfm and a transcript of the conference call will be posted on the Company's website.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is one of the nation's largest providers of home health, hospice and community care services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. GTIV-G

 

(unaudited tables and notes follow)


 

Gentiva Health Services, Inc. and Subsidiaries

Condensed Consolidated Financial Statements and Supplemental Information

(Unaudited)

 









(in 000's, except per share data)

2nd Quarter


Six Months




2014



2013



2014



2013


Condensed Statements of Comprehensive Income (Loss)














Net revenues

$

498,040



$

414,424



$

985,545



$

830,015




Cost of services sold

267,350



218,947



540,418



440,520




Gross profit

230,690



195,477



445,127



389,495




Selling, general and administrative expenses

(189,103)



(161,937)



(378,123)



(321,814)




Goodwill and other long-lived asset impairment







(224,320)




Interest income

633



642



1,266



1,427




Interest expense and other

(25,322)



(22,790)



(50,453)



(45,868)




Income (loss) before income taxes

16,898



11,392



17,817



(201,080)




Income tax (expense) benefit

(6,899)



(4,829)



(7,320)



587




Net income (loss)

9,999



6,563



10,497



(200,493)




Less: Net loss (income) attributable to noncontrolling interests

12



(216)



(172)



(337)




Net income (loss) attributable to Gentiva shareholders

$

10,011



$

6,347



$

10,325



$

(200,830)


















Total comprehensive income (loss)

$

9,999



$

6,563



$

10,497



$

(200,493)

















Earnings per Share














Net income (loss) attributable to Gentiva shareholders:














Basic

$

0.28



$

0.21



$

0.28



$

(6.51)




Diluted

$

0.27



$

0.20



$

0.28



$

(6.51)


















Weighted average shares outstanding:














Basic

36,298



30,941



36,243



30,863




Diluted

36,927



31,239



36,790



30,863


 

 


(in 000's)






Condensed Balance Sheets







ASSETS

Jun 30, 2014


Dec 31, 2013



Cash and cash equivalents

$

106,155



$

86,957




Accounts receivable, net (A)

280,731



289,905




Deferred tax assets

24,287



28,153




Prepaid expenses and other current assets

54,773



64,746




Total current assets

465,946



469,761












Notes receivable from CareCentrix

28,471



28,471




Fixed assets, net

44,948



49,375




Intangible assets, net

253,178



256,282




Goodwill

390,081



390,081




Other assets

67,927



68,647




Total assets

$

1,250,551



$

1,262,617











LIABILITIES AND EQUITY








Current portion of long-term debt

$

49,200



$

45,325




Accounts payable

14,585



15,659




Payroll and related taxes

55,239



64,857




Deferred revenue

48,936



43,864




Medicare liabilities

17,360



23,894




Obligations under insurance programs

76,605



82,634




Accrued nursing home costs

20,554



22,219




Accrued interest expense

17,010



17,239




Other accrued expenses

54,295



59,779




Total current liabilities

353,784



375,470












Long-term debt

1,111,972



1,124,432




Deferred tax liabilities, net

15,701



9,825




Other liabilities

54,822



53,084




Total deficit

(285,728)



(300,194)




Total liabilities and deficit

$

1,250,551



$

1,262,617












Common shares outstanding

36,846



36,375



(A) Accounts receivable, net included an allowance for doubtful accounts of $12.0 million and $10.7 million at June 30, 2014 and December 31, 2013, respectively.

 

 


(in 000's)










Six Months

Condensed Statements of Cash Flows

2014




2013



OPERATING ACTIVITIES:








Net income (loss)

$

10,497




$

(200,493)



Adjustments to reconcile net income (loss) to net cash provided by operating activities:









Depreciation and amortization

12,815




9,511




Amortization of debt issuance costs

3,181




6,463




Provision for doubtful accounts

3,800




2,680




Equity-based compensation expense

4,387




3,969




Windfall tax benefits associated with equity-based compensation

(21)




(82)




Goodwill and other long-lived asset impairment




224,320




Deferred income tax expense (benefit)

6,192




(7,983)



Changes in assets and liabilities, net of effects from acquisitions and dispositions:









Accounts receivable

5,374




(3,919)




Prepaid expenses and other current assets

9,973




1,727




Current liabilities

(24,242)




(27,705)



Other, net

678




1,678



Net cash provided by operating activities

32,634




10,166












INVESTING ACTIVITIES:








Purchase of fixed assets

(6,032)




(7,521)



Proceeds from the sale of businesses, net of cash transferred




508



Net cash used in investing activities

(6,032)




(7,013)












FINANCING ACTIVITIES:








Proceeds from issuance of common stock

1,276




1,852



Windfall tax benefits associated with equity-based compensation

21




82



Payment of contingent consideration accrued at acquisition date




(1,500)



Repayment of long-term debt

(9,163)




(25,000)



Minority interest capital contribution

1,160






Distribution to minority interests

(231)




(356)



Other

(467)




(161)



Net cash used in financing activities

(7,404)




(25,083)












Net change in cash and cash equivalents

19,198




(21,930)



Cash and cash equivalents at beginning of period

86,957




207,052



Cash and cash equivalents at end of period

$

106,155




$

185,122












SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

















Interest paid

$

47,224




$

39,069



Income taxes paid

$

341




$

522














Six Months

A reconciliation of Free cash flow to Net cash provided by operating activities follows:

2014




2013




Net cash provided by operating activities

$

32,634




$

10,166




Less: Purchase of fixed assets

(6,032)




(7,521)




Free cash flow

$

26,602




$

2,645


 


(in 000's)












Supplemental Information

2nd Quarter


Six Months




2014



2013



2014



2013


Segment Information (2)













Net revenues














Home Health

$

269,068



$

235,216



$

525,044



$

471,277




Hospice

172,322



179,208



346,724



358,738




Community Care

56,650





113,777





Total net revenues

$

498,040



$

414,424



$

985,545



$

830,015

















Operating contribution (4)














Home Health

$

41,027



$

29,917



$

70,630



$

60,105




Hospice

22,087



26,437



39,631



53,858




Community Care

8,507





17,786





Total operating contribution

71,621



56,354



128,047



113,963

















Corporate administrative expenses

(23,666)



(18,084)



(48,228)



(36,771)



Goodwill, intangibles and other long-lived asset impairment (5)







(224,320)



Depreciation and amortization

(6,368)



(4,730)



(12,815)



(9,511)



Interest expense and other, net

(24,689)



(22,148)



(49,187)



(44,441)



Income (loss) before income taxes

$

16,898



$

11,392



$

17,817



$

(201,080)

















Home Health operating contribution margin %

15.2%


12.7%


13.5%


12.8%


Hospice operating contribution margin %

12.8%


14.8%


11.4%


15.0%


Community Care operating contribution margin %

15.0%


—%



15.6%


—%



















2nd Quarter


Six Months


Net Revenues by Major Payer Source:

2014



2013



2014



2013




Medicare














Home Health

$

218,365



$

192,733



$

427,132



$

385,853




Hospice

161,514



167,788



324,723



335,061




Total Medicare

379,879



360,521



751,855



720,914




Medicaid and local government

70,733



18,664



141,859



36,934




Commercial insurance and other:














Paid at episodic rates

17,870



13,974



33,469



28,229




Other

29,558



21,265



58,362



43,938




Total commercial insurance and other

47,428



35,239



91,831



72,167




Total net revenues

$

498,040



$

414,424



$

985,545



$

830,015


 


2nd Quarter


Six Months

A reconciliation of Adjusted EBITDA to Net income (loss) attributable to Gentiva shareholders follows: (3)

2014



2013



2014



2013


          Adjusted EBITDA (3)

$

54,301



$

39,014



$

93,278



$

78,077


          Cost savings initiatives and acquisition and integration activities (4)

(4,659)



(744)



(10,000)



(885)


          Impact of closed locations

(942)





(2,714)




          Impact of merger related expenses

(745)





(745)




          Goodwill and other long-lived asset impairment (5)







(224,320)


          EBITDA (4)

47,955



38,270



79,819



(147,128)


          Depreciation and amortization

(6,368)



(4,730)



(12,815)



(9,511)


          Interest expense and other, net

(24,689)



(22,148)



(49,187)



(44,441)


          Income (loss) before income taxes

16,898



11,392



17,817



(201,080)


          Income tax (expense) benefit (6)

(6,899)



(4,829)



(7,320)



587


          Net income (loss)

9,999



6,563



10,497



(200,493)


          Less: Net loss (income) attributable to noncontrolling interests

12



(216)



(172)



(337)


          Net income (loss) attributable to Gentiva shareholders

$

10,011



$

6,347



$

10,325



$

(200,830)


 

A reconciliation of Adjusted income attributable to Gentiva shareholders to Net income (loss) (all items presented are net of tax): (3)














2nd Quarter


Six Months




2014



2013



2014



2013


















Adjusted income attributable to Gentiva shareholders

$

13,934



$

6,799



$

18,733



$

13,906




Cost savings initiatives and acquisition and integration activities (4)

(2,880)



(452)



(6,182)



(538)




Goodwill and other long-lived asset impairment (5)







(214,198)




Impact of closed locations

(595)





(1,778)






Impact of merger related expenses

(448)





(448)






Income (loss) attributable to Gentiva shareholders

10,011



6,347



10,325



(200,830)




Add back: Net (loss) income attributable to noncontrolling interests

(12)



216



172



337




Net income (loss)

$

9,999



$

6,563



$

10,497



$

(200,493)


















Adjusted income attributable to Gentiva shareholders per diluted share

$

0.38



$

0.22



$

0.51



$

0.45




Cost savings initiatives and acquisition and integration activities (4)

(0.08)



(0.02)



(0.17)



(0.02)




Goodwill and other long-lived asset impairment (5)







(6.94)




Impact of closed locations

(0.02)





(0.05)






Impact of merger related expenses

(0.01)





(0.01)






Income (loss) attributable to Gentiva shareholders per diluted share

0.27



0.20



0.28



(6.51)




Add back: Net income attributable to noncontrolling interests



0.01



0.01



0.01




Net income (loss) per diluted share

$

0.27



$

0.21



$

0.29



$

(6.50)


 

 




Operating Metrics

2nd Quarter


Six Months




2014



2013



2014



2013




Home Health














Episodic admissions

53,800



48,300



108,200



98,700




Total episodes

83,000



71,000



165,600



143,200




Episodes per admission

1.54



1.47



1.53



1.45




Revenue per episode

$

2,850



$

2,910



$

2,780



$

2,890


















Hospice














Admissions

11,900



12,100



24,800



25,700




Average daily census

12,900



12,800



12,900



12,800




Patient days (in thousands)

1,170



1,164



2,339



2,310




Revenue per patient day

$

147



$

154



$

148



$

155




Length of stay at discharge (in days)

107



97



106



98




Services by patient type:














Routine

99%



98%



99%



98%




General Inpatient & Other

1%



2%



1%



2%


















Community Care














Billed hours (in thousands)

4,200





8,500






Revenue per hour

$

13



$



$

13



$


Notes:

1. The comparability between reporting periods has been affected by the following items:

a. The Company completed the Harden transaction on October 18, 2013, affecting the reporting periods presented. Annualized net revenues of Harden at acquisition date approximated $145 million of Home Health, $110 million of Hospice and $221 million of Community Care. Net revenues specific to Harden for the second quarter and first six months of 2014 are not available as, subsequent to the acquisition date, the Company consolidated or closed a significant number of Harden branches in overlapping and smaller markets for which reporting of separate results is no longer available. As a result of this transaction, the Company's net revenues comparisons were positively impacted for both the second quarter and first six months of 2014 as compared to the corresponding periods of 2013.

b. The Company closed a significant number of branch operations relating to the branch rationalization initiative which began in 2013, affecting the reporting periods presented. As a result of these activities, the Company's net revenues comparisons were negatively impacted for the second quarter and first six months of 2014 by approximately $10 million and $18 million, respectively, as compared to the corresponding periods of 2013.

c. During the second quarter of 2013, the Company completed the acquisition of Hope Hospice, Inc.

2. The Company's senior management evaluates performance and allocates resources based on operating contributions of the operating segments, which exclude corporate expenses, depreciation, amortization, interest income, and interest expense and other, but include revenue and all other costs directly attributable to the specific segment. 

3. Adjusted EBITDA, a non-GAAP financial measure, is defined as income before interest expense and other (net of interest income), income taxes, depreciation and amortization and excluding charges relating to (i) cost savings initiatives and acquisition and integration activities, (ii) impact of closed locations, (iii) impact of merger related expenses and (iv) goodwill and other long-lived asset impairment. Management uses Adjusted EBITDA to evaluate overall performance and compare current operating results with other companies in the healthcare industry. Adjusted EBITDA should not be considered in isolation or as a substitute for income from continuing operations, net income, operating income or cash flow statement data determined in accordance with accounting principles generally accepted in the United States.  Because Adjusted EBITDA is not a measure of financial performance under accounting principles generally accepted in the United States and is susceptible to varying calculations, it may not be comparable to similarly titled measures in other companies.

Adjusted income attributable to Gentiva shareholders is defined as income attributable to Gentiva shareholders, excluding (i) charges relating to cost savings initiatives and acquisition and integration activities, (ii) impact of closed locations, (iii) impact of merger related expenses and (iv) goodwill and other long-lived asset impairment.

4. Operating contribution and EBITDA included charges relating to cost savings and acquisition and integration activities of $4.7 million and $10.0 million for the second quarter and first six months of 2014, respectively. For the second quarter and first six months 2013, the Company recorded charges of $0.8 million and $0.9 million, respectively, relating to cost savings and acquisition and integration activities.

For the second quarter and first six months of 2014, the Company recorded charges associated with cost savings initiatives of $1.4 million and $4.1 million, respectively. For the second quarter and first six months 2014, acquisition and integration activities of $3.3 million and $5.9 million, respectively, primarily related to the Company's acquisition of Harden. These costs consisted of legal, accounting and other professional fees and expenses.

For both the second quarter and first six months of 2013, the Company recorded restructuring costs of $0.2 million. For the second quarter and first six months of 2013, the Company recorded charges for acquisition and integration activities of $0.6 million and $0.7 million, respectively, primarily related to the Company's acquisition of Hope Hospice, Inc.

These charges were reflected as follows for segment reporting purposes (dollars in millions):


2nd Quarter


Six Months


2014


2013



2014


2013


Home Health

$


$



$

0.6


$


Hospice

2.5


0.7



5.4


0.7


Community Care

0.1




0.1



Corporate expenses

2.1


0.1



3.9


0.2


Total

$

4.7


$

0.8



$

10.0


$

0.9


5. During the first six months of 2013, the Company recorded non-cash charges of $224.3 million related to goodwill and other long-lived assets.

At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit due to lower than expected average daily census and higher than expected discharge rates during the first quarter. Based on the results of the interim impairment test, the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million.  As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million.

In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million.

6. The Company's effective tax rate was a tax provision of 40.8% and 41.1% for the second quarter and first six months of 2014, respectively, as compared to a tax provision of 42.4% and a tax benefit of 0.3% for the second quarter and first six months of 2013, respectively.

During the first six months of 2013, the Company recorded non-cash impairment charges of $224.3 million related to goodwill and other long-lived assets (see note 5).  Excluding the impact of the impairment charges, the Company's effective tax rate would have been 40.6% for the first six months of 2013.

Forward-Looking Statements

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: general economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; the impact on our Company of healthcare reform legislation and its implementation through governmental regulations; legislative proposals for healthcare reform; changes in Medicare, Medicaid and commercial payer reimbursement levels; the outcome of any inquiries into the Company's operations and business practices by governmental authorities; compliance with any corporate integrity agreement affecting the Company's operations; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; ability to access capital markets; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to severe weather conditions, natural disasters, pandemic outbreaks, terrorist acts or cyber-attacks; availability, effectiveness, stability and security of the Company's information technology systems; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; ability to maintain compliance with its financial covenants under the Company's credit agreement; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission, including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 31, 2013.

Financial and Investor Contact:


Eric Slusser


770-951-6101


eric.slusser@gentiva.com

or

John Mongelli


770-951-6496


john.mongelli@gentiva.com



Media Contact:


Scott Cianciulli


Brainerd Communicators


212-986-6667


cianciulli@braincomm.com

 

 

SOURCE Gentiva Health Services, Inc.



RELATED LINKS
http://www.gentiva.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.